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Lactic acid bacteria (LABs) are widely used in the
manufacturing of fermented food and are among the best-
studied microorganisms. Detailed knowledge of a number of
physiological traits has opened new potential applications for
these organisms in the food industry, while other traits might
be beneficial for human health. Important new developments
have been made in the research of LABs in the areas of
multidrug resistance, bacteriocins and quorum sensing,
osmoregulation, proteolysis, autolysins and bacteriophages.
Recently, progress has been made in the construction of food-
grade genetically modified LABs.
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Abbreviations
ABC ATP-binding cassette
GMO genetically modified organism
LABs lactic acid bacteria
MDR multidrug resistance system
Introduction
Lactic acid bacteria (LABs) belong to a group of Gram-pos-
itive anaerobic bacteria that excrete lactic acid as their main
fermentation product into the culture medium. LABs were
among the first organisms to be used in food manufactur-
ing. Today LABs play crucial roles in the manufacturing of
fermented milk products, vegetables and meat, as well as in
the processing of other products such as wine. In order to
understand and especially to manipulate the roles of these
LABs in these fermentation processes, LABs have been
studied extensively and are now among the best-charac-
terised microorganisms with respect to their genetics,
physiology and applications. The relative simplicity of
LABs makes them excellent candidates for complete analy-
sis of the metabolic pathways in the near future. Currently
the genomes of several LABs are being sequenced and the
first completely sequenced genome of the LAB Lactococcus
lactis IL1403 has recently been presented [1••].
The extensive knowledge gained of LABs has opened new
possibilities for their application. Tailor-made LABs with
desired physiological traits can be constructed and can be
applied to optimise the food manufacturing processes or to
manipulate the organoleptic properties (i.e. the overall
flavour and texture) of the products [2••]. In this review we
concentrate on a number of physiological traits of LABs that
have received significant attention recently for the reason
that they might lead to exciting new applications of LABs.
Multidrug resistance
Since the introduction of antibiotics around 1940, many
pathogens have developed antimicrobial drug-resistance
mechanisms. Different mechanisms of resistance in clini-
cal isolates have been identified, including alterations of
drug targets, modification of the drugs and reduced access
of the drug to the intracellular target. In many microor-
ganisms the reduced access of a variety of drugs was found
to be the result of active drug-efflux systems. These so-
called multidrug resistance systems (MDRs) are mainly
responsible for the intrinsic or acquired resistance of
microorganisms to antimicrobial drugs.
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Figure 1
ATP-binding cassette transporters in
Lactococcus lactis. (a) The oligopeptide
transport system (Opp) uptakes peptides that
have been processed by PrtP. OppA binds
the peptide and donates it to the translocator
complex of Opp in the membrane. (b) The
multidrug transporter LmrA functions as a
homologous dimer. Antimicrobial drugs are
picked up in the inner leaflet and extruded in a
medium. (c) The glycine-betaine-uptake
system is activated by hyperosmotic stress.
The glycine-betaine-binding domain
(OpuABC) is linked to the translocator
domain and the ABC-binding cassette domain
(OpuAA).
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In the LAB L. lactis, two multidrug-resistance transporters
were found to confer resistance to cationic lipophilic cyto-
toxic compounds [3]. One of these transporters belongs to
the major facilitator family and is called LmrP, while the
other MDR is an ATP-binding cassette (ABC)-transporter,
termed LmrA (Figure 1). Interestingly, this LmrA is the
first ABC-transporter found in bacteria to confer multidrug
resistance. Both LmrP and LmrA can excrete a wide vari-
ety of cytotoxic compounds, including the cytotoxic agents
used in treatment of cancer cells [4].
LmrP and LmrA have been genetically and functionally
characterised. The proteins have been solubilised from the
membrane, purified and functionally reconstituted in lipo-
somes [5••]. LmrP catalyses the excretion of lipophilic
cationic compounds in exchange with protons and is
responsible for L. lactis resistance to a variety of antibiotics,
in particular those belonging to the group of macrolides
and tetracyclins (M Putman, HW van Veen, JE Degener,
WN Konings, unpublished data).
The other multidrug transporter of L. lactis, LmrA, is half
the size of the human MDR1 P-glycoprotein, which is a
heterologous dimer. P-glycoprotein plays a crucial role in
the resistance of cancer cells against chemotherapeutic
agents. Surprisingly, LmrA has about 50% similarity with
each half of P-glycoprotein and functions as an homolo-
gous dimer [6••,7]. These observations demonstrate that
these types of MDRs have been extensively conserved all
the way from bacteria to man [4]. LmrA is not only a struc-
tural but also a functional homolog of P-glycoprotein.
LmrA extrudes the same substrates and is sensitive to the
same modulators as P-glycoprotein [6••].
The mechanism of extrusion of cytotoxic compounds by
LmrP and LmrA has been studied in whole cells, isolated
membrane vesicles and proteoliposomes. These studies
revealed that the lipophilic substrates intercalate rapidly in
the outer leaflet of the membrane. Subsequently, the sub-
strate flips over slowly to the inner leaflet from where it is
picked up by LmrP or LmrA and extruded in a proton motive
force or ATP-dependent process to the external medium [8].
This ‘vacuum-cleaner’ activity of LmrP and LmrA has subse-
quently been confirmed for P-glycoprotein [9].
Recently, the role of LmrA in the resistance of L. lactis to
antibiotics has been studied. Expression of LmrA in
Escherichia coli confers this organism resistant to 17 out of
the 21 clinically most used antibiotics, including antibi-
otics belonging to the classes of aminoglycosides,
cephalosporins, macrolides, penicillins, quinolones, strep-
togramins and tetracyclins [10]. Thus, LmrA has the
broadest substrate specificity reported for MDRs. In
another LAB Lactobacillus brevis, a homolog of LmrA was
found that confers resistance to the iso-alpha acids that are
present in hop in the natural brewing process
(K Sakamoto, A Margolles, HW van Veen, WN Konings,
unpublished data). This LmrA homolog is encoded by the
gene horA, which is located on a resistance plasmid. In
view of the role of LmrA and HorA in multidrug resistance,
it appears that these transporters may contribute to the
intrinsic-drug resistance of the organisms in which they are
expressed. Since bacteria are prone to gene exchange via
conjugative or mobilisable plasmids and transposons to
enhance their survival in drug containing habitats, a role
for LmrA and HorA in acquired-drug resistance of (patho-
genic) bacteria needs to be considered.
So far, homologs of LmrA and HorA have been found in
the genome sequences of Bacillus subtilis and the patho-
genic bacteria Staphylococcus aureus, E. coli, Helicobacter
pylori, Haemophilus influenza and Mycoplasma genitali-
um [11]. In view of the extremely broad substrate
specificity of LmrA, the role of these homologous systems
in the antibiotic resistance of these pathogenic organisms
should be seriously considered.
Bacteriocins and quorum sensing
Bacteriocins (i.e. peptide antibiotics that are primarily
lethal to other strains and species of bacteria) are produced
by almost all genera of LABs, and can be divided in two
main classes: the lantibiotics, which are post-translational-
ly modified peptides, and the linear antimicrobial
peptides. Interesting features of these peptides, apart from
their possible applications either as food preservatives or as
a basis for food-grade genetic modification and expression
systems, are that they can interact with various different
biomacromolecules. The lantibiotic nisin, which is one of
the most potent bacteriocins, is known to be able to inter-
act with at least nine structurally different compounds
(Table 1), depending on its stage of biosynthesis and on its
location. First, this small peptide can interact with other
proteins — for example, those involved in the immunity
mechanisms or the NisK signal transducer involved in
‘quorum sensing’ [12••]. Second, nisin can also ‘dock’ on
Table 1




NisI/NisFEG Immunity; membrane proteins
NisK Sensor histidine kinase





NisP Processing of leader nisin-peptide
NisB Dehydration
NisC Lanthionine-formation
the membrane-localised cell-wall precursor lipid II,
enabling efficient membrane binding and probably also
enhancing pore-formation [13•]. Third, nisin forms short-
lived pores in biological membranes by interactions with
neighbouring nisin molecules and with surrounding phos-
pholipids, thereby killing the target bacteria [14]. 
Nisin and various other (linear) antimicrobial or
pheromone peptides are sensed by LABs by quorum-
sensing systems that enhance bacteriocin production
when a certain threshold concentration of bacteriocin is
reached [15,16]. The signal transducer NisK which sens-
es nisin can be engineered in such a way that it has
inverted sensor properties (i.e. constitutive promoter
activity in the absence of bacteriocin and down-regulation
of transcription in the presence of bacteriocin) [17•]. The
knowledge on quorum sensing of LABs by means of their
bacteriocin (or inducer peptide) concentration has led to
the development of highly efficient, versatile, broad-host
range controlled gene expression systems [18], which
allow high overproduction of desired proteins, even those
that are intrinsically toxic for the producing cell.
In the case of linear unmodified bacteriocins, such as plan-
taricins, carnobacteriocins and sakacins, the induction of
bacteriocin synthesis is more complex. Specific-inducing
peptides or peptide pheromones are produced that lack
antimicrobial activity, but these peptides serve to stimulate
production of the bacteriocin(s) typically encoded in the
same gene cluster [19–23]. Also in some of these cases
inducible gene expression systems could be developed.
Undoubtedly, the advanced understanding of signalling
mechanisms and the mode of action of bacteriocins will
lead to useful applications in such diverse fields as gene
expression systems, fighting multidrug resistance by pro-
viding alternatives for classic antibiotics [13•] and food
applications by serving as natural preservatives.
Osmoregulation
Maintenance of cell turgor is a prerequisite for almost any
form of life as it is critical for growth and provides the
mechanical force for the expansion of the cell wall. Since
changes in extracellular osmotic pressure have the same
physicochemical effects on cells from all biological king-
doms, the responses to osmotic stress may be similar in all
organisms [24••,25]. Generally, (micro)organisms respond
to hyperosmotic stress by rapidly accumulating compatible
solutes to prevent the loss of water and loss of turgor pres-
sure. Physiological studies on osmoregulation have
revealed that the amino acids, glutamate and proline, and
the quaternary ammonium compounds, glycine betaine
(plant origin) and carnitine (animal origin), are the most
important compatible solutes used by bacteria from various
genera to protect themselves against hyperosmotic stress.
A range of studies indicates that in the LABs Lactobacillus
plantarum, L. lactis and Listeria monocytogenes glycine
betaine and carnitine are the preferred compatible solutes.
These compounds are taken up via transport systems that
are activated upon hyperosmotic stress, whereas they are
rapidly excreted by channel-like activities upon osmotic
downshock [24••,26,27,28•].
The molecular properties of the hyperosmotic-stress-activat-
ed glycine-betaine-uptake system of L. lactis have recently
been established. The system is essential for growth under
hyperosmotic conditions and is probably paradigmatic for
many osmotic upshift-activated transporters in (lactic acid)
bacteria. The uptake of glycine betaine in L. lactis is effected
by a unique ABC transporter (OpuA) that is composed of two
different polypeptides (Figure 1). One of the subunits,
OpuABC, comprises the glycine-betaine-binding domain
linked to the translocator domain and the other subunit,
OpuAA, comprises the ABC domain (Figure 1) [28•,29,30•].
Since binding-protein-dependent transporters generally
function with two translocator and two ABC domains, the
implication of the structure of OpuA is that two glycine-
betaine-binding domains are present per functional unit.
Furthermore, this work shows that ligand-binding proteins in
Gram-positive bacteria are not necessarily associated with
the outer surface of the cytoplasmic membrane via a lipid
modification, but that in some systems the binding protein is
linked to the cell surface via the integral membrane protein
domain. Database searches indicate that several not yet char-
acterised systems share the same architecture as OpuA. A
clear advantage of this architecture is that protein purifica-
tion and membrane reconstitution is facilitated, which has so
far hampered the functional analysis of binding-protein-
dependent ABC transporters. The purified and
membrane-reconstituted OpuA system is fully functional in
sensing and responding to changes in medium osmolari-
ty [28•]. Preliminary data indicate that osmotic activation of
OpuA involves the sensing of changes in the physical prop-
erties of the membrane bilayer that are brought about by the
changes in medium osmolarity.
Hyperosmotic conditions are frequently used to preserve
food products. In general, rather high concentrations of
salts or sugars are needed to prevent outgrowth of spoilage
or pathogenic bacteria. By interfering with the osmoregu-
lated transporters directly or the signal transduction
components that affect their expression, one will be able to
apply milder conservation methods and thus improve the
quality (i.e. flavour, texture) of the product without com-
promising the safety of the consumer.
Proteolysis
LABs are multiple amino acid auxotrophs that utilise exoge-
nous proteins such as caseins as a source of amino acids. The
first step in the hydrolysis of b -casein by L. lactis is its pro-
tein breakdown by an extracellular cell wall bound
proteinase PrtP. The activity of PrtP results in 5–30 amino
acids fragments of casein that can subsequently be taken up
by the cells for internal hydrolysis by a variety of peptidas-
es. The role of the individual proteinases and peptidases in
the proteolysis process has been assessed by constructing
strains in which the expression of one or more enzymes is
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lowered or increased. Since all these constructs have been
made with food grade vectors, they can be used in the milk
fermentation processes and the products can be evaluated
by taste panels. In this way genetically modified LABs have
been obtained that can be used in the production of cheeses
with different organoleptic properties [31•,32].
A crucial step in the proteolysis process is the uptake of the
relatively large peptides that are released by PrtP. This
uptake is catalysed by an ATP-driven and binding-protein-
dependent oligopeptide transport system Opp (Figure 1).
The uptake of peptides of up to 10 amino acids has been
shown in vivo using a mutant that is deficient in five pepti-
dases and monitoring of intracelullar peptide accumulation
by mass spectrometry [33••]. Subsequent specificity and
size-restriction studies have shown that peptide fragments
up to at least 18 residues can be taken up via Opp [34].
Clearly, this oligopeptide transporter has a different peptide
spectrum than the homologous systems of E. coli and
Salmonella typhimurium, which have high binding affinities
for tri- and tetrapeptides. In contrast, Opp of L. lactis has
very low affinities for these small peptides, while it has high
affinities for larger peptides. This is reflected by the Kd-val-
ues of the L. lactis binding protein (OppA), which are
>1000, 2.2 and 0.8 m M for the homologous peptides
SLSQS, SLSQSKVLP and SLSQSKVLPVPQ, respective-
ly [35••]. Peptides with a relatively low affinity are taken up
with a comparable rate as those that have a high affinity
[33••], the uptake of the ‘high affinity’ peptides appears to
be rate-determined by the donation of the peptide from
OppA to the translocator complex of Opp in the membrane
[35••]. Transport of the low affinity peptides is not limited
by this donation step but rather by the binding of the pep-
tide to OppA. The notion that peptide uptake from
complex casein hydrolysates is not simply determined by
the affinity of peptide binding to OppA is supported by
studies of OppA specificity mutants [36]. The crucial role
of Opp in the proteolysis process is evident from the obser-
vation that an Opp-negative strain is unable to accumulate
and hydrolyse PrtP-generated peptides in milk.
Manipulation of the substrate spectrum of OppA by muta-
genis can lead to an altered use of the peptides that are
released in milk by PrtP and can affect the flavour devel-
opment during cheese ripening.
Autolysins, cheese ripening and oral vaccination
Environmental conditions leading to bacteriolysis of LABs
have long been known. Many strains of LABs autolyse
when incubated under conditions of ‘unbalanced growth’,
which results in an inhibition of further cell wall peptido-
glycan biosynthesis. For L. lactis it has been shown that
cellular lysis observed during stationary phase is caused by
the action of its major muramidase, AcmA. An AcmA-nega-
tive strain did not autolyse and formed long chains of
non-separated cells. AcmA, thus, appears to be a major
enzyme in determining cheese flavour development as
AcmA-induced autolysis liberates flavour-forming enzymes
in the cheese matrix.
The AcmA-negative strain of L. lactis was recently used to
investigate the mechanism behind bacteriocin-induced
lysis often observed in lactococci. Although the wild-type
strain lysed upon addition of a number of different bacteri-
ocins, the AcmA-negative strain did not. Apparently, the
depletion of energy caused by the increase of membrane
permeability brought about by the bacteriocins terminated
wall synthesis, while the autolysin continued to break down
the cell wall (CM Martìnez-Cuesta, J Kok, E Herranz,
C Peláez, T Requena, G Buist, unpublished data).
AcmA is a modular enzyme: the active domain is in the
amino terminus, while the carboxyl terminus contains a
stretch of 45 amino acid residues that is repeated three
times. Recently, it was shown that this repeat domain is
involved in binding of the enzyme to its substrate, the cell
wall [37•]. Interestingly, the cell wall anchor domain has a
broad specificity as is indicated by the binding of AcmA to
cells of a large number of Gram-positive bacteria. Although
AcmA is anchored to the cell wall through its carboxyl ter-
minus, part of the protein is released into the culture
medium. Various active but truncated forms of AcmA were
identified that lacked one or more repeats. Using geneti-
cally labelled strains it was shown that the released
autolysin was able to attach to and lyse an autolysin-nega-
tive strain of L. lactis. Indeed, it was recently shown that
the amidase also disrupts chains of Streptococcus ther-
mophilus [38]. Again, in an indirect way, AcmA could be of
importance to the performance of mixed strain starters.
The autolysin AcmA is hydrolysed by the lactococcal
extracellular serine proteinase (caseinase) PrtP (see
above) [39•]. The extent of AcmA degradation is largely
determined by the proteolytic specificity of the proteinase.
Consequently, the proteinase has a dual role in determin-
ing flavour formation during milk fermentation for cheese
production. On the one hand, PrtP determines the compo-
sition of the initial casein breakdown products, and thus,
the availability of substrates for the peptidases. On the
other hand, it is involved in the degradation of AcmA, and
in this way modulates the extent of starter cell lysis and
release of intracellular flavour determining enzymes, such
as peptidases and amino acid convertases.
The ability of the repeat domain of AcmA to bind to bacteri-
al cells when added to these cells from the outside has
recently resulted in a entirely new and exciting possibility to
use non-genetically modified LABs for oral vaccina-
tion [40••]. By hooking up the repeat domain to other proteins
through genetic engineering techniques, foreign antigens
were presented on the surface of L. lactis in order to elicit the
production of protective antibodies at mucosal surfaces.
LABs and bacteriophage
All LABs are prone to phage attack and phage are among
the main causes of fermentation failure. Consequently,
phages are of great economic significance, a notion that has
resulted in a major and worldwide effort to defeat them. 
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Two principally different routes have been taken to do
this. First, the dairy industry has improved fermentation
process technology to prevent phage infection. Air filtra-
tion, direct vat inoculation, the use of closed vats and
phage-resistant strains as well as starter culture rotation are
all daily practice in modern-day milk fermentation opera-
tions. However, all these technological advances have not
eliminated phage as a serious threat, partly because the
bacteria themselves are the source of phage. Many strains
of LABs carry within their own genome a copy of a phage
chromosome. It may even be common to find several,
intact and/or remnant, phage genomes in one bacterial
chromosome [1••]. Although still a matter of debate, it
seems that in at least some LAB species lytic phages may
have evolved from temperate phage [41]. 
The second approach in the conquest of phages exploits
the tremendous potential of molecular biology tools cur-
rently available to the researcher in this area. The advance
of molecular genetic methodology applicable to LABs,
together with large-scale nucleotide sequencing tech-
niques, has especially led to a tremendous increase in our
knowledge of LAB phages. The chromosomes of thirteen
phages infecting LABs, both temperate and lytic species,
have been completely sequenced, allowing a thorough
understanding of their structural and functional organisa-
tion [42••]. One of the major conclusions that can be drawn
from comparing the phage genomes is that they are all
highly organised: functionally related genes are clustered,
with the clusters forming modules encoding proteins with
a specific biological function. This modular organisation is
seen as highly important to phage evolution, as recombi-
nation between partially homologous phages or
interactions of phages with the host genome could lead to
phages with new properties. From comparing phage
genome sequences in more detail, however, it is clear that
the theory of module exchange is too simplified: the mod-
ule of genetic exchange can be as small as a gene
(fragment). LAB phage evolution seems to be the result of
a complex of modular exchanges combined with other
genetic alterations such as deletions, inversions, duplica-
tions and point mutations [43•].
The dynamic evolutionary properties of phages have led to
a search for natural as well as knowledge-based novel
strategies to bridle their proliferation. Currently, each step
in the phage life cycle (adsorption, DNA injection and
replication, phage assembly and host lysis) can be specifi-
cally blocked and a number of the mechanisms have
already been exploited in LAB strain improvement pro-
grammes [44,45]. 
Bacterial phage/host interactions also remain of prime
interest to the future (dairy) fermentation industry. Among
LABs are several bacteria that are potentially probiotic
(Greek for ‘pro-life’) that, when administered to man or
animal, benificially affect the host by improving the prop-
erties of the indigenous microflora. As the trait of the LAB
in question may be exhibited only by one strain, its large-
scale cultivation for use in a probiotic food may be very
sensitive to phage attack. It would seem of utmost impor-
tance to thwart, already in an early stage, the emergence of
phage attacking such strains.
Food-grade approaches employing genetically
modified LABs
To optimally use the physiological and genetic properties
of LABs described above, it is of great importance to
develop safe, stable and (cost) effective food-grade genet-
ic modification, selection and expression tools. A recent
review [46•] describes state-of-the-art approaches to selec-
tion and modification methods and to (inducible) gene
expression systems. The following criteria are important
for developing sustainable food-grade systems employing
genetically modified organisms (GMOs) (modified
from [46•]).
1. The selection of safe hosts, which should be well char-
acterised, stable and with a long history of safe use.
2. The use of hosts that are food-compatible and devoid of
unwanted selection markers such as antibiotic resistance.
3. The use of food-grade modification tools and genetic
elements, preferably derived from self-cloning.
4. To never produce any harmful compounds (assessment of
side-effects of the genetic modification might be necessary).
5. To be suitable for large industrial scale applications or
for direct use in food products.
To conform to these criteria, food-grade selection and
modification systems have been developed for various
LABs [46•]. Food-grade selection markers include those
based on sugar utilisation (lactose, sucrose), auxothrophic
markers [47], and those that confer resistance or immunity
to certain food-grade compounds, such as against bacteri-
ocins. Nice examples that meet most of the criteria
mentioned above are provided by Platteeuw et al. [48],
who developed a versatile set of cloning and expression
vectors for application in self-cloning based on lactose
selection with lacF as a marker and lacA as an inducible
promoter. More recently a system for a food-grade multi-
ple-copy integration of desired DNA-fragments for L. lactis
was described [49] that employs lactococcal plasmids and a
pediococcal selection marker. Various inducible gene
expression systems (e.g. based on lactose-, nisin-, phage-,
NaCl-responding or purine-regulated promoters) have
been developed, which all have their unique advantages
and drawbacks [50].
A first example of the use of one of these systems in a real
cheese application was described by de Ruyter et al. [51].
The NICE (nisin-controlled expression) system was used
for the controlled lysis of L. lactis, where induction can
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conveniently take place through in situ induction in curd
by inclusion of low quantities of a nisin-producing strain.
Significant enhancement of cheese ripening could be
achieved by this approach, which is currently under inves-
tigation. A completely different approach that circumvents
the inclusion of live GMOs in food products was recently
described. A system was developed for anchoring previ-
ously produced recombinant proteins to host LAB cells by
use of anchoring domains of LAB proteins (e.g. the repeat-
ed anchoring domain of the major lactococcal autolysin
AcmA) [52•]. In this way cell-surface display of hybrid pro-
teins can be achieved, yielding cells that can be exploited
as oral vaccines (see above), for enzyme- or whole-cell
immobilisation, for protein delivery to various environ-
ments such as the human gastrointestinal-tract or food
products. Last but not least, recent developments in high-
throughput technologies, such as genome sequencing and
DNA-arrays, enable functional genomics efforts, which
support GMO analysis to assess possible undesired side-
effects of the genetic modification, and thus providing
concrete tools to eventually ensure the safety of GMOs
used in food products [53].
Conclusions
The extensive knowledge that has now been accumulated
about the physiology and genetics of LABs has led to a
detailed understanding of several traits of these relatively
simple bacteria. This knowledge can be used for
improved as well as new applications of these organisms in
food manufacturing. In addition, several properties of
LABs may turn out to have clinical relevance and a num-
ber of strains may have health beneficial effects. For a
number of physiological properties found in bacteria
LABs have been proven to be excellent organisms for
advanced analysis. Moreover, LABs are increasingly used
as model organisms for physiological and genetic studies
especially of Gram-positive bacteria. 
Acknowledgements
The authors thank the present and previous members of the Departments
of Molecular Microbiology and Molecular Genetics for their valuable
contribution to the research presented in this review. The research on LABs
in both departments has been supported by research grants from the
European community.
References and recommended reading
Papers of particular interest, published within the annual period of review,
have been highlighted as:
• of special interest
••of outstanding interest
1. Bolotin A, Mauger S, Malarme K, Ehrlich SD, Sorokin A: Low
•• redundancy sequencing of the entire Lactococcus lactis IL1403
genome. Antonie van Leeuwenhoek 1999, 1-4:27-76.
The complete genome of the lactic acid bacterium, Lactococcus lactis, is
presented and provides many entries for the study of metabolism and phys-
iology of this group of organisms.
2. Venema G, Kok J, van Sinderen D: From DNA sequence to
•• application: possibilities and complications. Antonie van
Leeuwenhoek 1999, 1-4:3-26.
A comprehensive review of the sophisticated genetic tools that have been
developed for lactic acid bacteria (LABs). These tools have facilitated
tremendously the increase of fundamental and application-oriented knowl-
edge of LABs and their bacteriophages. 
3. Bolhuis H, Molenaar D, Poelarend G, van Veen HW, Poolman B,
Driessen AJM, Konings WN: Proton motive force and ATP-
dependent drug extrusion systems in multidrug-resistant
Lactococcus lactis. J Bacteriol 1994, 176:6957-6964.
4. van Veen HW, Konings WN: Multidrug transporters from bacteria to
man: similarities in structure and function. Sem Cancer Biol 1997,
8:183-191.
5. van Veen HW, Margolles A, Putman M, Sakamoto K, Konings WN:
•• Structure-function analysis of multidrug transporters in
Lactococcus lactis. Biochim Biophys Acta 1999, 1461:201-206.
An overview is given of the stucural and functional properties of the mul-
tidrug transporters found in L. lactis.
6. van Veen HW, Callaghan R, Soceneantu L, Sardini A, Konings WN,
•• Higgins CF: A bacterial antibiotic-resistance gene that
complements the human multidrug resistance P-glycoprotein
gene. Nature 1998, 391:291-295.
The L. lactis multidrug resistance system (MDR) LmrA can functionally be
expressed in human cells and functions in these cells as the endogenous
multidrug transporter P-glycoprotein. This observation shows how strongly
MDRs have been conserved from bacteria to man.
7. van Veen HW, Margolles A, Muller M, Callaghan R, Martin C,
Higgins CF, Konings WN: The homo-dimeric ATP-binding cassette
transporter LmrA mediates multidrug transport by an alternating
two-site (two cylinder engine) mechanism. EMBO J 2000,
in press.
8. Bolhuis H, van Veen HW, Molenaar D, Poolman B, Driessen AJM,
Konings WN: Multidrug resistance in Lactococcus lactis: evidence
for ATP-dependent drug extrusion from the inner leaflet of the
cytoplasmic membrane. EMBO J 1996, 15:239-4245.
9. Shapiro AB, Corder AB, Ling V: P-glycoprotein-mediated Hoechst
33342 transport out of the lipid bilayer. Eur J Biochem 1997,
250:115-121.
10. Putman M, van Veen HW, Degener JE, Konings WN: Antibiotic
resistance era of the multidrug resistance pump. Mol Microbiol
2000, in press.
11. van Veen HW, Margolles A, Putman M, Sakamoto K, Konings WN:
Multidrug resistance in lactic acid bacteria: molecular mechanism
and clinical relevance. Antonie van Leeuwenkoek 1999,
76:347-352.
12. van Kraaij C, de Vos WM, Siezen RJ, Kuipers OP: Lantibiotics:
•• biosynthesis, mode of action and applications. Nat Prod Rep
1999, 16:575-587.
A recent review on the best-characterised lantibiotic nisin, describing biosyn-
thesis, sensing, immunity and mode of action mechanisms.
13. Breukink E, Wiedemann I, van Kraaij C, Kuipers OP, Sahl H-G, de
• Kruijff B: Use of the cell wall precursor lipid II by a pore-forming
peptide antibiotic. Science 1999, 286:2361-2364.
This paper shows that non-proteinaceous and non-lipidic molecules can
interact with certain antimicrobial peptides, such as nisin. Nisin is shown
to use the same docking molecule as vancomycin (i.e. lipid II) a finding
that could lead to the development of a novel class of antibiotics to fight
multidrug resistance.
14. Moll GN, Konings WN, Driessen AJM: Bacteriocins: mechanism of
membrane insertion and pore formation. Antonie van
Leeuwenhoek 1999, 1-4:185-198.
15. Kuipers OP, Beerthuyzen MM, de Ruyter PGGA, Luesink EJ,
de Vos WM: Autoregulation of nisin biosynthesis in Lactococcus
lactis by signal transduction. J Biol Chem 1995, 270:27299-27304.
16. Kleerebezem M, Quadri LEN, Kuipers OP, de Vos WM: Quorum
sensing by peptide pheromones and two-component signal-
transduction systems in Gram-positive bacteria. Mol Microbiol
1997, 24:895-904.
17. Kleerebezem M, de Vos WM, Kuipers OP: The lantibiotics nisin and
• subtilin act as extracellular regulators of their own biosynthesis.
In Cell-Cell Signaling in Bacteria. Edited by Dunny GM, Winans SC.
Washington DC: American Society for Microbiology, 1999:159-174.
This chapter describes the latest findings in signalling and sensing mecha-
nisms involved in nisin and subtilin biosynthesis
18. Kuipers OP, de Ruyter PGGA, Kleerebezem M, de Vos WM: Quorum
sensing-controlled gene expression in lactic acid bacteria.
J Biotech 1999, 64:15-21.
19. Quadri LEN, Kleerebezem M, Kuipers OP, de Vos WM, Roy KL,
Vederas JC, Stiles ME: Characterization of a locus from
Carnobacterium piscicola LV17B involved in bacteriocin
Lactic acid bacteria Konings et al.    281
production and immunity: evidence for global inducer-mediated
transcriptional regulation. J Bacteriol 1997, 179:6163-6171.
20. Brurberg MB, Nes IF, Eijsink VG: Pheromone-induced production of
antimicrobial peptides in Lactobacillus. Mol Microbiol 1997,
26:347-360.
21. Anderssen EL, Diep DB, Nes IF, Eijsink VGH, Nissen-Meijer J:
Antagonistic activity of Lactobacillus plantarum C11: two new
two-peptide bacteriocins, Plantaricins EF and JK, and the
induction factor Plantaricin A. Appl Environ Microbiol 1998,
6:2269-2272.
22. Risoen PA, Havarstein LS, Diep DB, Nes IF: Identification of the
DNA-binding sites for two response regulators involved in control
of bacteriocin synthesis in Lactobacillus plantarum C11. Mol Gen
Genet 1998, 259:224-232.
23. Hauge HH, Mantzilas D, Moll GN, Konings WN, Driessen AJ,
Eijssink VG, Nissen-Meijer J: Plantaricin is an amphiphilic alpha-
helical bacteriocin-like pheromone which exerts antimicrobial and
pheromone activities through different mechanisms. Biochem
1998, 37:16026-16032.
24. Poolman B, Glaasker E: Regulation of compatible solute
•• accumulation in bacteria. Mol Microbiol 1998, 29:397-407.
This paper gives an overview of the possible mechanisms of osmotic regu-
lation of transport processes.
25. Galinski EA, Trüper HG: Microbial behaviour in salt stressed
ecosystems. FEMS Microbiol Rev 1999, 15:95-108.
26. Glaasker E, Tjan FB, Ter Steeg PF, Konings WN, Poolman B: The
physiological response of Lactobacillus plantarum towards salt
and non-electrolyte stress. J Bacteriol 1998, 180:4718-4723.
27. Glaasker E, Heuberger EHML, Konings WN, Poolman B: Mechanism
of osmotic activation of the quaternary ammonium compound
transporter (QacT) of Lactobacillus plantarum. J Bacteriol 1998,
180:5540-5546.
28. Van der Heide T, Poolman B: Osmoregulated ABC-transport
• system of Lactococcus lactis senses water stress via changes in
physical state of the membrane. Proc Natl Acad Sci USA 2000,
in press.
The purified and membrane-reconstituted ABC-transporter for glycine
betaine has osmosensor and osmoregulator activities. The osmotic regulation
is mediated by changes in the physical state of the surrounding membrane.
29. Obis D, Guillot A, Gripon JC, Renault P, Bolotin A, Mistou MY:
Genetic and biochemical characterization of a high-affinity
betaine uptake system (BusA) in Lactococcus lactis reveals a new
functional organization within bacterial ABC transporters.
J Bacteriol 1999, 181:6238-6246.
30. van der Heide T, Poolman B: Glycine betaine transport in
• Lactococcus lactis is osmotically regulated at the level of
expression and translocation. J Bacteriol 2000, 182:203-206.
This paper gives an overview of the possible mechanisms of osmotic regu-
lation of transport processes.
31. Christensen JE, Dudley EG, Pederson JA, Steele JL: Peptidases and
• amino acid catabolism in lactic acid bacteria. Antonie van
Leeuwenhoek 1999, 1-4:217-246.
This paper presents a comprehensive overview of our current knowledge of
the proteolytic systems of lactic acid bacteria
32. Siezen RJ: Multidomain, cell-envelope proteinases of lactic acid
bacteria. Antonie van Leeuwenhoek 1999, 1-4:139-158.
33. Kunji ERS, Fang G, Jeronimus-Stratingh MC, Bruins AP, Poolman B,
•• Konings WN: Reconstruction of the pathway for utilization of b -
casein by Lactococcus lactis. Mol Microbiol 1998, 27:1007-1118.
This paper gives an in vivo approach to study proteolysis and peptide trans-
port using complex peptide mixtures.
34. Detmers F, Kunji ERS, Lanfermeijer FC, Poolman B, Konings WN:
Kinetics and specificity of peptide uptake by the oligopeptide
transport system of Lactococcus lactis. Biochem 1998,
37:16671-16679.
35. Lanfermeijer F, Picon A, Konings WN, Poolman B: Kinetics and
•• consequences of binding of nona- and dodecapeptides to the
oligopeptide binding protein, OppA, of Lactococcus lactis.
Biochem 1999, 8:14440-14450.
This paper presents a detailed analysis of the interaction of peptides with the
binding protein of the oligopeptide transport system.
36. Picon A, Kunji ERS, Lanfermeijer FC, Konings WN, Poolman B:
Specificity mutants in the binding protein, OppA, of the
oligopeptide transport system of Lactococcus lactis. J Bacteriol,
2000, 182:1600-1608.
37. Buist G: AcmA of Lactococcus lactis, a cell-binding major
• autolysin [Thesis]. Groningen, The Netherlands: University of
Groningen; 1997.
In this thesis a new cell wall binding domain of AcmA is identified and char-
acterised. This work is the basis for a totally new (future) use of lactic acid
bacteria as non-genetically modified organism vehicles for (oral) vaccination. 
38. Mercier C, Tremblay J, Kulakauskas S: Muramidases as
Intermediates of Interactions between bacteria. In Proceedings of
the 6th Symposium on Lactic Acid Bacteria: 1999 Sept 19-23;
Veldhoven, the Netherlands. 1999: abstract G60.
39. Buist G, Venema G, Kok J: Autolysis of Lactococcus lactis is
• influenced by proteolysis. J Bacteriol 1998, 180:5947-5953.
This paper shows for the first time that lactococcal autolysin is prone to
degradation by lactococcal proteinase, a process that depends on pro-
teinase specificity and localisation. As such, it should direct future strain
improvement programmes for cheese flavour acceleration. 
40. Leenhouts K, Buist G, Kok J: Anchoring of proteins to lactic acid
•• bacteria. Antonie van Leeuwenhoek 1999, 76:367-376.
This review gives a concise update on the types of cell wall anchoring mod-
ules identified in lactic acid bacteria and the future possibilities of using
these in (oral) vaccination.
41. Josephsen J, Neve H: Bacteriophages and lactic acid bacteria. In Lactic
Acid Bacteria, Microbiology and Functional Aspects, edn 2. Edited by
Salminen S, Wright A. New York: Marcel Dekker Inc.; 1998:385-436.
42. Stanley E, Fitzgerald GF, van Sinderen D: Comparative genomics of
•• bacteriophage infecting lactic acid bacteria. In The Lactic Acid
Bacteria, The Genetics of the LAB, vol 3. Edited by Warner P, Wood
BJB. Aspen, Maryland: USA; 2000:in press.
This paper gives an in depth survey of the (partial and complete) genomes
of all lactic acid bacteria phages sequenced to date.
43. Brüssow H, Bruttin A, Desiere F, Lucchini S, Foley S: Molecular
• ecology and evolution of Streptococcus thermophilus
bacteriophages — a review. Virus Gen 1998, 16:95-109.
This paper gives the latest information on the evolution of a number of S. ther-
mophilus phage on the basis of the nucleotide sequences of their genomes.
44. Allison GE, Klaenhammer TK: Phage resistance mechanisms in
lactic acid bacteria. Int Dairy J 1998, 8:207-226.
45. Forde A, Fitzgerald GF: Bacteriophage defence systems in lactic
acid bacteria. Antonie van Leeuwenhoek 1999, 76:89-113.
46. de Vos WM: Safe and sustainable systems for food-grade
• fermentations by genetically modified lactic acid bacteria. Intern
Dairy J 1999, 9:3-10.
An up-to-date overview of developments in the design and construction of
safe genetically modified lactic acid bacteria, including selection and modi-
fication systems and gene expression systems.
47. Dickely F, Nilsson D, Hansen EB, Johansen E: Isolation of
Lactococcus lactis nonsense suppressors and construction of a
food-grade cloning vector. Mol Microbiol 1995, 15:839-847.
48. Platteeuw C, van Alen-Boerrigter I, van Schalkwijk S, de Vos WM:
Food-grade cloning and expression system for Lactococcus lactis.
Appl Environ Microbiol 1996, 62:1008-1013.
49. Leenhouts K, Bolhuis A, Venema G, Kok J: Construction of a food-
grade multiple-copy integration system for Lactococcus lactis.
Appl Microbiol Biotechnol 1998, 49:417-423.
50. Djordjevic GM, Klaenhammer TR: Inducible gene expression
systems in Lactococcus lactis. Mol Biotechnol 1998, 9:127-139.
51. de Ruyter PGGA, Kuipers OP, Meijer WC, de Vos WM: Food-grade
controlled lysis of Lactococcus lactis for accelerated cheese
ripening. Nat Biotechnol 1997, 15:976-979.
52. Leenhouts K, Buist G, Kok J: Anchoring of proteins to lactic acid
• bacteria. Antonie van Leeuwenhoek 1999, 76:367-376.
Recent developments in using cell-wall attachment approaches with value
for development of oral vaccine and other delivery systems for lactic acid
bacteria with desired properties.
53. Kuipers OP: Genomics for food biotechnology: prospects of the
use of high-throughput technologies for the improvement of food
microorganisms. Curr Opin Biotechnol 1999, 10:511-516.
282 Ecology and industrial microbiology 
